Stock listing

NASDAQ:BIOS BioPlus Acquisition Corp Stock

Follow BioPlus Acquisition Corp into a list and get an email when it puts out news.

Delisted NASDAQ:BIOS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:BIOS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

BioPlus Acquisition Corp on 6ix

Decks
3 decks · latest Jun 14, 2023

Decks

DeckKindSlidesDate
Merger or Acquisition (June 2023)Merger or acquisition36 slidesJun 14, 2023
SPAC Merger (May 2023)SPAC merger36 slidesMay 30, 2023
SPAC Merger (May 2023)SPAC merger43 slidesMay 3, 2023

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Louis G Lange
Other companies: NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Epiphany Technology Acquisition Corp (Director · Sep 16, 2022 – Sep 16, 2022 · Past); Audentes Therapeutics Inc (Director · Jul 19, 2016 – Jan 15, 2020 · Past); Esperion Therapeutics, Inc. (Director · Jun 25, 2013 – Jul 1, 2013 · Past); Maxygen Inc (Director · May 27, 2010 – Jun 6, 2012 · Past)
Director · Dec 2, 2021 – Dec 2, 2021 · Past
Shawn Cross
Other companies: Pacira BioSciences, Inc. (Chief Financial Officer · Since at least Oct 21, 2024); Cyclo Therapeutics Inc (Director · Dec 27, 2023 – Feb 27, 2025 · Past); Applied Molecular Transport Inc (CEO & Chair of the Board, Director · Jun 4, 2020 – Dec 27, 2023 · Past); GT Biopharma, Inc. (Chief Executive Officer, Director · Nov 16, 2017 – Nov 16, 2017 · Past)
Director · Dec 2, 2021 – Dec 2, 2021 · Past
Jonathan Rigby
Other companies: Oncolytics Biotech Inc. (Director · Since at least Jan 1, 2026); SteadyMed Ltd (President and CEO, Director · Dec 28, 2017 – Aug 30, 2018 · Past)
Chief Business Officer, Director · Dec 2, 2021 – Dec 2, 2021 · Past
Glen GiovannettiDirector · Dec 2, 2021 – Dec 2, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about BioPlus Acquisition Corp.